We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$592M
AUM Growth
-$7.66M
Cap. Flow
-$9.36M
Cap. Flow %
-1.58%
Top 10 Hldgs %
42.35%
Holding
83
New
Increased
25
Reduced
31
Closed
3

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$711K
2
PAYX icon
Paychex
PAYX
+$550K
3
ABBV icon
AbbVie
ABBV
+$359K
4
DHR icon
Danaher
DHR
+$328K
5
STT icon
State Street
STT
+$309K

Sector Composition

Rank Sector Weight
1 Healthcare 37.27%
2 Technology 13.27%
3 Industrials 11.13%
4 Consumer Staples 8.62%
5 Energy 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGNC icon
76
AGNC Investment
AGNC
$12.7B
-19,700
Closed -$420K
NSC icon
77
Norfolk Southern
NSC
$76.7B
-2,000
Closed -$206K
PFE icon
78
Pfizer
PFE
$143B
-6,269
Closed -$207K

Similar funds

Tirschwell & Loewy's Q2 2015 Portfolio in Review

As of Q2 2015, Tirschwell & Loewy held 83 positions worth $592M, down 1.3% from $600M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 3.6%. Tirschwell & Loewy opened no new positions and exited 3, leaving the 83-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 37% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy added most to Biogen in Q2 2015, an estimated $711K increase.
  • Tirschwell & Loewy's biggest Q2 2015 reduction was Nektar Therapeutics, cutting an estimated $6.18M.
  • Tirschwell & Loewy fully exited AGNC Investment in Q2 2015, selling an estimated $420K.
  • Tirschwell & Loewy's ten largest holdings make up 42% of its $592M portfolio in Q2 2015.
  • Tirschwell & Loewy opened 0 new positions and closed 3 in Q2 2015.
  • Tirschwell & Loewy's portfolio value fell 1.3% quarter-over-quarter to $592M.

Based on Tirschwell & Loewy's 13F filing for Q2 2015, filed 6 Aug 2015.